+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitor therapy and hip fracture risk



Proton pump inhibitor therapy and hip fracture risk



JAMA 297(13): 1429; Author Reply 1429-30




(PDF emailed within 0-6 h: $19.90)

Accession: 055260251

Download citation: RISBibTeXText

PMID: 17405964

DOI: 10.1001/jama.297.13.1429-a


Related references

Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture. Yearbook of Endocrinology 2008: 206-208, 2008

Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296(24): 2947-2953, 2006

Long-term proton pump inhibitor therapy and risk of hip fracture (vol 296, pg 2947, 2006). JAMA (Journal of the American Medical Association) 297(5): 470, 2007

Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor. Journal of Gastroenterology and Hepatology 33(3): 623-630, 2017

Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?. Gastroenterologia Y Hepatologia 31(6): 400-401, 2008

Hip fracture and proton pump inhibitor therapy: position statement. Canadian Journal of Gastroenterology 22(10): 855-858, 2008

Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients. American Journal of Kidney Diseases, 2016

Chronic proton pump inhibitor use is not associated with an increased risk of osteoporotic fracture. 2007

The relationship between proton pump inhibitor adherence and fracture risk in the elderly. Calcified Tissue International 94(6): 597-607, 2014

Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. Canadian Journal of Gastroenterology 19(6): 350-358, 2005

Examining the potential relationship between proton pump inhibitor use and the risk of bone fracture. Gastroenterology & Hepatology 7(12): 831-833, 2012

Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm. American Journal of Gastroenterology 103(10): 2428-2431, 2008

Proton Pump Inhibitor Use and Fracture Risk: An Update of Drug Safety Communication Needed?. American Journal of Gastroenterology 2019, 2019

Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis. Journal of Bone Metabolism 25(3): 141-151, 2018

Proton Pump Inhibitor Use, H2-Receptor Antagonist Use, and Risk of Incident Clinical Vertebral Fracture in Women. Calcified Tissue International: -, 2018